Katie W. Finley Email and Phone Number

Co-chair the US Launch Leadership Team responsible for delivering company’s first product launch; Board endorsement of US Go-To-Market Strategy.• Delivered brand strategy including defining positioning, messaging, segmentation, and engagement decisions; collaborate across the business to deliver synergistic planning and budgets.• Attract, hire, and develop a team of talented Marketers; champion and build innovative Marketing capabilities.• Build effective and compliant relationships… Show more Co-chair the US Launch Leadership Team responsible for delivering company’s first product launch; Board endorsement of US Go-To-Market Strategy.• Delivered brand strategy including defining positioning, messaging, segmentation, and engagement decisions; collaborate across the business to deliver synergistic planning and budgets.• Attract, hire, and develop a team of talented Marketers; champion and build innovative Marketing capabilities.• Build effective and compliant relationships with KOLs for strategy enhancement; work closely with Medical Affairs to ensure a one-company approach. Show less

• Developed commercial strategic framework to drive company towards becoming a fully integrated biopharmaceutical company.• Pioneered the company's first Commercial Operating Model to enhance operations, governance, and process.• Secured Board endorsement for US Digital Strategy, leading to successful funding for digital roadmap and marketing technology architecture.

*Deployed new digital products business (B2B) vertical with full accountability for P&L and budget (achieved via business case buy-ups). *Successfully introduced Unify™ (a platform for vaccines inventory intelligence) across US health systems. *Pioneered an industry-first Enterprise-level Artificial Intelligence (AI) partnership serving as the analytical workbench for upcoming AI-driven digital offerings.

*Reported to Global President of $3B business, responsible for driving demand growth in G7 markets and maximizing LOE brand performance; efforts resulted in >$70M revenue upside *Tasked by senior leadership to lead team of 75+ Commercial colleagues globally to deliver Pfizer separation and Mylan integration milestones, including preparing Operating Model of new entity, Viatris.

Reported to Regional President of $4B business, led strategic projects, including business development, to deliver business objectives; active member of commercial leadership team

Oversaw P&L for 7 rare disease brands in 9 markets with net sales of over $100M; achieved 104% of revenue goals while improving operating profit by 18%

Led development of the Global (ex-US) strategic plan including defining product commercial value and identifying licensing partnerships in Europe

Responsible for HCP launch campaign ($23M budget) and implementation of key tactics supporting expanded label of pivotal radiographic data.

Promoted each year to roles with increasing scope and responsibility based on exceptional performance: Associate Product Manager (2008), Product Manager (2009), Product Manager II (2010), Senior Manager (2011)

Selected from an international pool of applicants to participate in elite leadership development program1. US Payer Marketing, DUAVEE®, Women’s Health (2008)2. Sales Representative, Specialty and Primary Care Medicine; sold Protonix and Effexor XR (2007)3. Analytics & Insights, Neuroscience New Products, Alzheimer's Disease & Schizophrenia (2006)4. MBA Associate, ZOSYN® US Marketing Intern, Infectious Disease Franchise (Summer 2005)